Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FIGY
Barclays ETN+ FI Enhanced Global High Yield ETN
FIGY
|
+$1.09B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$984M |
| 3 |
Pfizer
PFE
|
+$895M |
| 4 |
Johnson & Johnson
JNJ
|
+$862M |
| 5 |
American Express
AXP
|
+$773M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.04% |
| 2 | Technology | 14.87% |
| 3 | Healthcare | 12.6% |
| 4 | Consumer Staples | 8.81% |
| 5 | Consumer Discretionary | 8.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Union Pacific
UNP
$172B
| $826K | ﹤0.01% |
+10,708
| New | +$807K |
|
327
Williams-Sonoma
WSM
$27.5B
| $808K | ﹤0.01% |
+28,930
| New | +$780K |
|
328
Dover
DOV
$27.5B
| $767K | ﹤0.01% |
+14,728
| New | +$738K |
|
|
AGN
329
DELISTED
Allergan Inc
AGN
| $759K | ﹤0.01% |
+9,015
| New | +$935K |
|
330
Petrobras
PBR
$123B
| $757K | ﹤0.01% |
+56,472
| New | +$962K |
|
331
PNC Financial Services
PNC
$99.2B
| $757K | ﹤0.01% |
+10,386
| New | +$719K |
|
332
United Parcel Service
UPS
$89.5B
| $706K | ﹤0.01% |
+8,159
| New | +$700K |
|
|
TWX
333
DELISTED
Time Warner Inc
TWX
| $686K | ﹤0.01% |
+12,381
| New | +$701K |
|
334
Mondelez International
MDLZ
$80.5B
| $652K | ﹤0.01% |
+22,839
| New | +$695K |
|
335
Bristol-Myers Squibb
BMY
$132B
| $648K | ﹤0.01% |
+14,503
| New | +$630K |
|
336
Amgen
AMGN
$209B
| $633K | ﹤0.01% |
+6,413
| New | +$665K |
|
337
Nike
NKE
$62.7B
| $628K | ﹤0.01% |
+19,708
| New | +$613K |
|
338
Rogers Communications
RCI
$18.4B
| $593K | ﹤0.01% |
+15,130
| New | +$717K |
|
339
Freeport-McMoran
FCX
$91.2B
| $588K | ﹤0.01% |
+21,312
| New | +$650K |
|
340
Southwest Gas
SWX
$6.54B
| $582K | ﹤0.01% |
+12,448
| New | +$606K |
|
|
UN
341
DELISTED
Unilever NV New York Registry Shares
UN
| $575K | ﹤0.01% |
+14,636
| New | +$602K |
|
|
CMCSK
342
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
| $550K | ﹤0.01% |
+13,875
| New | +$550K |
|
343
Stryker
SYK
$133B
| $541K | ﹤0.01% |
+8,370
| New | +$556K |
|
344
Booking.com
BKNG
$150B
| $532K | ﹤0.01% |
+16,100
| New | +$492K |
|
|
CELG
345
DELISTED
Celgene Corp
CELG
| $528K | ﹤0.01% |
+9,030
| New | +$543K |
|
346
Lockheed Martin
LMT
$132B
| $518K | ﹤0.01% |
+4,779
| New | +$488K |
|
347
Colgate-Palmolive
CL
$73.3B
| $516K | ﹤0.01% |
+9,004
| New | +$534K |
|
348
Sumitomo Mitsui Financial
SMFG
$164B
| $500K | ﹤0.01% |
+54,220
| New | +$484K |
|
349
iShares MSCI ACWI ETF
ACWI
$32.7B
| $495K | ﹤0.01% |
+9,902
| New | +$512K |
|
350
Phillips 66
PSX
$84.4B
| $494K | ﹤0.01% |
+8,391
| New | +$527K |
|
Similar funds
Ken Fisher's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Ken Fisher, which disclosed 525 positions worth $38.5B. Its ten largest holdings account for 21% of the portfolio.
Its largest position is Barclays ETN+ FI Enhanced Global High Yield ETN: 11,772,806 shares worth $1.05B.
By sector, the portfolio is most concentrated in Financials at 16% of assets, followed by Technology and Healthcare.
- Ken Fisher's largest Q2 2013 buy was Barclays ETN+ FI Enhanced Global High Yield ETN: 11,772,806 shares worth $1.05B.
- Ken Fisher's ten largest holdings make up 21% of its $38.5B portfolio in Q2 2013.
- Ken Fisher disclosed 525 positions in Q2 2013, its first 13F filing on record.
Based on Fisher Asset Management's 13F filing for Q2 2013, filed 16 Jul 2013.